New €6 million ophthalmology hospital opens in Alba Iulia
The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.

Romanian wholesale trade turnover (excluding motor vehicles and motorcycles) increased by 2.3% in the first three months of 2026 compared to the same period last year, according to data published by the National Institute of Statistics (INS).
The Board of Directors of Intesa Sanpaolo Bank Romania has acknowledged the resignation of Alessio Cioni from his roles as General Manager and Chairperson of the Management Committee (CEO).
Monza Ares Group, one of Romania's largest private networks focused on cardiology and complex surgery, and Brain Institute, the country's leading private neurosurgery centre, have merged to create one of Romania's largest private medical service platforms.
Electro-Alfa International, a Romanian manufacturer of electrical equipment and provider of EPC and IT services, reported revenue growth and profitability for Q1 2026. The company's total revenues reached €25.7 million, up 12.2% compared to Q1 2025. Net profit increased by 2.9% to €6.2 million, supported by a 2% increase in EBITDA, which reached €10.6 million.
Romanian energy group Electrica recorded a 58.2% surge in net profit for Q1 2026, driven by a transition back to competitive market mechanisms following the removal of price capping schemes.